Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. MDT
2. ENOV
3. AON
4. AZN
5. BLSM
6. SPY
7. GRMN
8. TXNM
9. JFB
10. YEXT

Go back to Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada
(NYSE: HIMS) Delayed: 29.58 --0 (-0%)
Previous Close $29.58    52 Week High $ 
Open $29.28    52 Week Low $ 
Day High $29.75    P/E N/A 
Day Low $29.07    EPS $ 
Volume 453,109